Fact Sheet PDF

Market: Copenhagen

Symbol: CHR

ISIN: DK0060227585

Chr. Hansen is a global bioscience company that develops natural solutions for the food, nutritional, pharmaceutical and agricultural industries. We develop and produce cultures, enzymes, probiotics and HMOs for a variety of foods, beverages, dietary supplements, animal feed and crop protection.

Share Data	06/12/2024
Currency	DKK
Previous Close	549.60
52 Weeks %	-0.15
Volume	0
Number of Shares	131,852,496
Market Cap (bil.)	72.5

Previous Close	Currency	52 Weeks %	Volume	Number of Shares	Market Cap (bil.)
549.60	DKK	-0.15	0	131,852,496	72.5

Key figures, EUR million


Income statement (cont. operations)	2022/23	2021/22	2020/21	2019/20	2018/19
Revenue	1,334.4	1,218.0	1,077.4	970.0	937.4
Gross profit	723.3	676.5	613.4	584.0	576.9
EBITDA before special items	472.2	432.9	399.3	400.6	372.3
EBIT before special items	358.3	325.8	298.1	326.9	314.7
EBIT	337.0	320.9	276.2	313.0	312.4
Net financial items	(29.0)	(20.0)	(22.5)	(13.5)	(16.1)
Profit from continuing operations	227.0	225.1	198.7	231.6	229.2
Profit from discontinued operations	-	-	646.5	13.4	21.0
Profit for the year	227.0	225.1	845.2	245.0	250.2

Cash flow (Group)	2022/23	2021/22	2020/21	2019/20	2018/19
Cash flow from operating activities	316.9	308.8	310.8	364.6	298.6
Cash flow from investing activities	(176.3)	(152.4)	284.5	(807.5)	(81.6)
Free cash flow	140.6	156.4	595.3	(442.9)	217.0
Free cash flow before acquisitions and special items	-	-	183.9	244.5	229.1
Free cash flow before acquisitions and special items, cont. operations	201.7	172.1	196.4	224.9	220.2

Balance sheet (Group)	2022/23	2021/22	2020/21	2019/20	2018/19
Total assets	3,430.5	3,316.8	3,114.2	2,853.6	2,057.8
Invested capital	3,062.3	2,934.7	2,793.1	2,487.6	1,745.3
Net working capital	291.9	228.6	190.1	166.2	171.8
Equity	1,900.2	1,823.9	1,626.1	893.0	797.2
Net interest-bearing debt	931.7	880.6	898.2	1,345.0	734.4

Key ratios	2022/23	2021/22	2020/21	2019/20	2018/19

Continuing operations
Organic growth ¹⁾, %	11	9	7	6	8
Gross margin, %	54.2	55.5	56.9	60.2	61.5
EBITDA margin before special items, %	35.4	35.5	37.1	41.3	39.7
EBIT margin before special items, %	26.9	26.8	27.7	33.7	33.6
EBIT margin, %	25.3	26.3	25.6	32.3	33.3
ROIC excl. goodwill, %	24.1	24.0	24.8	33.6	39.2
ROIC, %	12.0	11.4	11.6	16.5	20.0
R&D, %	7.7	8.1	8.5	8.0	8.1
Capital expenditure, %	10.2	11.6	14.5	12.2	12.6
Earnings per share diluted, EUR	1.72	1.71	1.51	1.76	1.74
Average number of employees (FTEs)	3,757	3,693	3,398	2,932	2,768

Group
Earnings per share diluted, EUR	1.72	1.71	6.41	1.86	1.90
Net debt to EBITDA before special items	2.0x	2.0x	2.3x	3.1x	1.8x

Following the classification of the Natural Colors business as discontinued operations in 2019/20, the business is presented separately on an aggregated level in the income statement, balance sheet and cash flow statement. In accordance with IFRS, the income statement and cash flow statement have both been restated in previous periods, while the balance sheet has not been restated in previous periods.

Numbers are not restated and therefore not directly comparable

IFRS16 was implemented using the retrospective approach, and comparative figures for 2018/19 have not been restated.

¹⁾ Organic growth: Increase in revenue adjusted for sales reduction, acquisitions and divestments, and measured in local currency.